These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9123418)
1. Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. Walgenbach KJ; Llull R; Murase N; Starzl TE; Hirner A Transplant Proc; 1997; 29(1-2):1542. PubMed ID: 9123418 [No Abstract] [Full Text] [Related]
2. Long-term survival of limb allografts after weaning of cyclosporine: possible role of microchimerism. Durlik M; Lukomska B; Namysłowski A; Janczewska S; Cybulska E; Olszewski WL Transplant Proc; 1997; 29(1-2):1226-7. PubMed ID: 9123285 [No Abstract] [Full Text] [Related]
3. Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat. Jiang H; Yang XF; Soriano R; Fujitsu T; Kobayashi M Transplant Proc; 1999; 31(1-2):1203-5. PubMed ID: 10083538 [No Abstract] [Full Text] [Related]
4. Association of down-regulation of cytokine activity with rat hind limb allograft survival. Fealy MJ; Most D; Huie P; Wolf M; Sibley RK; Morris RE; Press BH Transplantation; 1995 May; 59(10):1475-80. PubMed ID: 7539555 [TBL] [Abstract][Full Text] [Related]
6. Cytokines are involved in the rejection of small intestine allografts. Hayashi M; Martinez OM; Krams SM; Burns W; Esquivel CO Transplant Proc; 1997 May; 29(3):1802. PubMed ID: 9142277 [No Abstract] [Full Text] [Related]
7. Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection. Zamfirescu DG; Owen E; Lascar I; Molitor M; Zegrea I; Popescu M; Bishop GA; Lauer CA; Simionescu M; Climov M; Lanzetta M Transplant Proc; 2009 Mar; 41(2):503-8. PubMed ID: 19328913 [TBL] [Abstract][Full Text] [Related]
8. Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. Walgenbach KJ; Heeckt PF; Stanson JD; Whiteside TL; Bauer AJ Transplant Proc; 1996 Oct; 28(5):2454. PubMed ID: 8907896 [No Abstract] [Full Text] [Related]
9. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation. Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605 [TBL] [Abstract][Full Text] [Related]
10. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467 [No Abstract] [Full Text] [Related]
12. Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. Kuroki H; Bean MA; Ikuta Y; Burgess EM Transplant Proc; 1991 Dec; 23(6):3282-4. PubMed ID: 1721436 [No Abstract] [Full Text] [Related]
13. High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication. Wynn C; Pan F; Erickson L; Ebbs A; Kobayashi M; Jiang H Transplant Proc; 2002 Aug; 34(5):1387-9. PubMed ID: 12176408 [No Abstract] [Full Text] [Related]
14. Acute rejection of rat renal allografts is influenced by the presence of a native kidney. Grau V; Herbst B; Steiniger B Transplant Proc; 1997 May; 29(3):1723. PubMed ID: 9142247 [No Abstract] [Full Text] [Related]
15. Use of CD14 and lipopolysaccharide binding protein mRNA expression as markers for acute rejection in rat small bowel transplantation. Cicalese L; Freeswick PD; Watkins SC; Kelly E; Zeidan M; Rao AS; Stanko RT Transplant Proc; 1996 Oct; 28(5):2470. PubMed ID: 8907907 [No Abstract] [Full Text] [Related]
16. Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. Ebbs A; Pan F; Wynn C; Erickson L; Kobayashi M; Jiang H Transplant Proc; 2002 Aug; 34(5):1378-81. PubMed ID: 12176404 [No Abstract] [Full Text] [Related]
17. Accelerated arteriosclerosis in aortic grafts: a role for cytokines in progressive intimal lesion development. Geerling RA; Ansari AA; LaFond-Walker AM; Baumgartner WA; Wesselingh S; Herskowitz A Transplant Proc; 1998 Jun; 30(4):946-7. PubMed ID: 9636381 [No Abstract] [Full Text] [Related]
18. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression. Rintala JM; Savikko J; Rintala SE; von Willebrand E Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234 [TBL] [Abstract][Full Text] [Related]
19. Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat. Yeh LS; Gregory CR; Griffey SM; Lecouter RA; Hou SM; Morris RE Transplantation; 1997 Sep; 64(6):919-22. PubMed ID: 9326421 [TBL] [Abstract][Full Text] [Related]
20. In vivo changes in acute rejection of rat small bowel allografts. Stojanovic T; Schlemminger R; Bedke J; Gröne HJ; Heuser M; Leister I; Hecker M; Becker H; Markus PM Transplant Proc; 2000 Sep; 32(6):1247-8. PubMed ID: 10995931 [No Abstract] [Full Text] [Related] [Next] [New Search]